Abstract
Biopolymers and their composites have been extensively investigated in recent years for multiple applications, especially in environmental, medical, and pharmaceutical fields. Bacterial cellulose (BC) has emerged as a novel biomaterial owing to its nontoxic, high-liquid absorbing and holding capacity, drug-carrying ability, and pollutant absorbing features. Additionally, its web-shaped three-dimensional (3D) structure and hydrogen bonding sites have incited a combination of various nanoparticles, polymers, and other materials with BC in the form of composites. Such BC-based composites have been developed through in-situ, ex-situ, and solution casting methods for targeted applications, such as air and water filters, controlled drug delivery systems, wound dressing materials, and tissue regeneration. This review details the production and development of BCbased composites with different materials and by various methods. It further describes various applications of BC-based composites in the environmental and pharmaceutical sectors, with specific examples from the recent literature. This review could potentially appeal a wide readership in these two emerging fields, where novel and advanced materials for different applications have been developed on a regular basis using BC as the base material.
Keywords: Bacterial cellulose, production, composites, environmental applications, pharmaceutical applications, tissue regeneration.
Current Pharmaceutical Design
Title:Potential Applications of Bacterial Cellulose in Environmental and Pharmaceutical Sectors
Volume: 26 Issue: 45
Author(s): Mazhar Ul-Islam, Salman Ul-Islam, Sumayia Yasir, Atiya Fatima, Md. Wasi Ahmed, Young Sup Lee, Sehrish Manan and Muhammad Wajid Ullah*
Affiliation:
- Department of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan 430074,China
Keywords: Bacterial cellulose, production, composites, environmental applications, pharmaceutical applications, tissue regeneration.
Abstract: Biopolymers and their composites have been extensively investigated in recent years for multiple applications, especially in environmental, medical, and pharmaceutical fields. Bacterial cellulose (BC) has emerged as a novel biomaterial owing to its nontoxic, high-liquid absorbing and holding capacity, drug-carrying ability, and pollutant absorbing features. Additionally, its web-shaped three-dimensional (3D) structure and hydrogen bonding sites have incited a combination of various nanoparticles, polymers, and other materials with BC in the form of composites. Such BC-based composites have been developed through in-situ, ex-situ, and solution casting methods for targeted applications, such as air and water filters, controlled drug delivery systems, wound dressing materials, and tissue regeneration. This review details the production and development of BCbased composites with different materials and by various methods. It further describes various applications of BC-based composites in the environmental and pharmaceutical sectors, with specific examples from the recent literature. This review could potentially appeal a wide readership in these two emerging fields, where novel and advanced materials for different applications have been developed on a regular basis using BC as the base material.
Export Options
About this article
Cite this article as:
Ul-Islam Mazhar , Ul-Islam Salman , Yasir Sumayia, Fatima Atiya , Ahmed Wasi Md. , Lee Sup Young, Manan Sehrish and Ullah Wajid Muhammad *, Potential Applications of Bacterial Cellulose in Environmental and Pharmaceutical Sectors, Current Pharmaceutical Design 2020; 26 (45) . https://dx.doi.org/10.2174/1381612826666201008165241
DOI https://dx.doi.org/10.2174/1381612826666201008165241 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Anti-Cancer Agents in Medicinal Chemistry Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle
Current Medicinal Chemistry Recent Patents on Light Based Therapies: Photodynamic Therapy, Photothermal Therapy and Photoimmunotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Novel Strategies and Tools for Enhanced Sensitivity in Routine Biomolecule Analytics
Current Pharmaceutical Analysis The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension
Vascular Disease Prevention (Discontinued) Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo
Anti-Cancer Agents in Medicinal Chemistry The Modulating Effects of Endogenous Substances on Drug Metabolising Enzymes and Implications for Inter-Individual Variability and Quantitative Prediction
Current Drug Metabolism Cutaneous Melanoma: Fishing with Chips
Current Molecular Medicine Erbin, a Negative Regulator in Diverse Signal Pathways
Current Protein & Peptide Science Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
Current Pharmaceutical Design The Bioanalytical Molecular Pharmacology of the N-methyl-<sub>D</sub>-Aspartate (NMDA) Receptor Nexus and the Oxygen-Responsive Transcription Factor HIF-1α : Putative Mechanisms and Regulatory Pathways Unravel the Intimate Hypoxia Connection
Current Molecular Pharmacology Adrenergic Receptors as Targets for Cancer Treatment - A Perspective for Future Studies
Current Cancer Therapy Reviews Cytosine Methyltransferases as Tumor Markers
Current Genomics Cordycepin Affects Multiple Apoptotic Pathways to Mediate Hepatocellular Carcinoma Cell Death
Anti-Cancer Agents in Medicinal Chemistry MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer
Current Cancer Drug Targets A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer
Current Drug Targets Antibacterial Peptides and Gastrointestinal Diseases
Current Pharmaceutical Design Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics
Anti-Cancer Agents in Medicinal Chemistry Lysophosphatidic Acid and Ischemic Stroke
Vascular Disease Prevention (Discontinued)